Market Place
Sourcing Support
Marathon Health Acquires Cerner Workforce Health Solutions Clinics
01 Aug 2023 //
BUSINESSWIRE
Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
30 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
The next Emflaza: Acer Therapeutics looks to take a page out of Marathon’s book
18 Jan 2018 //
ENDPTS
After disappointing 2016, new drug approvals roared back to life in 2017
02 Jan 2018 //
FIERCE BIOTECH
FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
22 Dec 2017 //
KHN
Lawmakers dig into `skyrocketing` MS costs with probe into 7 drugmakers
17 Aug 2017 //
FIERCE PHARMA
Embattled Marathon Pharma May Shutter Operations by May 1
25 Apr 2017 //
BIOSPACE
Marathon Pharmaceutical Drops Out Of PhRMA Following Drug Price Controversy
24 Apr 2017 //
KHN
Payer snubs PTC`s Emflaza, signaling pricing trouble ahead of launch
14 Apr 2017 //
FIERCE PHARMA
The Cost of Drugs for Rare Diseases Is Threatening the U.S. Health Care System
10 Apr 2017 //
HARVARD BUSINESS REVIEW
Bernie Sanders thinks this $89,000-a-year drug should be $1,000 a year
22 Mar 2017 //
MARKETWATCH
FDA`s orphan drug program under GAO scrutiny after senators allege abuse
22 Mar 2017 //
FIERCE PHARMA
Sky-High Drug Prices For Rare Diseases Show Why Orphan Drug Act Needs Reform
18 Mar 2017 //
HUFFINGTON POST
Marathon, under heavy fire for Emflaza pricing, makes surprise deal to sell drug
17 Mar 2017 //
FIERCE PHARMA
Single-digit price-hike pledge? J&J has that covered already
27 Feb 2017 //
FIERCE PHARMA
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston
27 Feb 2017 //
BIOSPACE
Pharma Lobby May Boot Company That Introduced High-Priced Drug
17 Feb 2017 //
BLOOMBERG
First Ariad, Now Senator Bernie Sanders Puts This Drug Company on Notice
16 Feb 2017 //
BIOSPACE
Lawmakers question pricing of drug for genetic disease
14 Feb 2017 //
MEDICAL XPRESS
Why Did That Drug Price Increase 6,000%? It`s The Law
11 Feb 2017 //
FORBES
Another biotech games the system, and everyone gets to pay for the fallout
10 Feb 2017 //
ENDPOINTS
Valeant defends its latest round of price increases but critics aren`t buying it
18 Oct 2016 //
FIERCE PHARMA
Marathon hopes to succeed where others have fallen with Duchenne NDA
14 Jun 2016 //
FIERCE BIOTECH
A failed Valeant battlecry: ‘We’re not like Turing in any way, shape or form’
09 May 2016 //
STAT
Novartis CEO Jimenez sees U.S. pricing power draining away
27 Jan 2016 //
FIERCE PHARMA
Shkreli-shaming spills over onto Valeant as Dems call CEO for price hikes
29 Sep 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.